Intriguingly, treatment with ALK inhibitors induced SOX4 expression in both the ALCL and lung ADC cell lines harbouring the two different ALK fusion genes (Supplementary Figure 6e). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.